Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 8152293)

1.

Experimental model for MDS-like myelodysplasia in transgenic mice harboring the SV40 large-T antigen under an immunoglobulin enhancer.

Inoue T, Hirabayashi Y, Mitsui H, Furuta Y, Suda Y, Aizawa S, Ikawa Y.

Leukemia. 1994 Apr;8 Suppl 1:S202-5.

PMID:
8152293
2.

MDS-like experimental myelodysplasia: multilineage abnormal hematopoiesis in transgenic mice harboring the SV40 large T antigen under an immunoglobulin enhancer.

Furuta Y, Aizawa S, Suda Y, Ikawa Y, Nishikawa S, Hayashi S, Hirabayashi Y, Inoue T.

Exp Hematol. 1993 Jun;21(6):806-15.

PMID:
8500578
3.
4.

Tumorigenesis in mice with an SV40 T antigen transgene driven by the immunoglobulin gamma 1 heavy chain germline promoter.

Dunnick W, Elenich L, Cunningham K, Chrisp C, Claflin L.

Curr Top Microbiol Immunol. 1995;194:163-9. No abstract available.

PMID:
7895490
8.

Reduction of early B lymphocyte precursors in transgenic mice overexpressing the murine heat-stable antigen.

Hough MR, Chappel MS, Sauvageau G, Takei F, Kay R, Humphries RK.

J Immunol. 1996 Jan 15;156(2):479-88.

PMID:
8543797
9.

SV40 T-antigen is a histocompatibility antigen of SV40-transgenic mice.

Wettstein PJ, Jewett L, Faas S, Brinster RL, Knowles BB.

Immunogenetics. 1988;27(6):436-41.

PMID:
2836306
10.

Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice.

Hentunen TA, Reddy SV, Boyce BF, Devlin R, Park HR, Chung H, Selander KS, Dallas M, Kurihara N, Galson DL, Goldring SR, Koop BA, Windle JJ, Roodman GD.

J Clin Invest. 1998 Jul 1;102(1):88-97.

11.

A mouse model for chronic lymphocytic leukemia based on expression of the SV40 large T antigen.

ter Brugge PJ, Ta VB, de Bruijn MJ, Keijzers G, Maas A, van Gent DC, Hendriks RW.

Blood. 2009 Jul 2;114(1):119-27. doi: 10.1182/blood-2009-01-198937. Epub 2009 Mar 30.

12.

AlphaIIb integrin expression during development of the murine hemopoietic system.

Corbel C, Salaün J.

Dev Biol. 2002 Mar 15;243(2):301-11.

PMID:
11884039
13.

Subcutaneous sarcomas of probable neuronal origin in a transgenic mouse strain containing an albumin promoter-fused simian virus 40 large T antigen gene.

Kawabuchi B, Nomura K, Ohtake K, Hino O, Aizawa S, Machinami R, Kitagawa T.

Jpn J Cancer Res. 1994 Jun;85(6):601-9.

PMID:
8063613
14.

Hemopoietic neoplasms in lethally irradiated mice repopulated with bone marrow cells carrying the human c-myc oncogene: a repopulation assay.

Hirabayashi Y, Inoue T, Suda Y, Aizawa S, Ikawa Y, Kanisawa M.

Exp Hematol. 1992 Feb;20(2):167-72.

PMID:
1544384
15.

Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice.

Yukawa K, Kikutani H, Inomoto T, Uehira M, Bin SH, Akagi K, Yamamura K, Kishimoto T.

J Exp Med. 1989 Sep 1;170(3):711-26.

16.

Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter.

Danks RA, Orian JM, Gonzales MF, Tan SS, Alexander B, Mikoshiba K, Kaye AH.

Cancer Res. 1995 Oct 1;55(19):4302-10.

17.

Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen.

Nitta M, Katabuchi H, Ohtake H, Tashiro H, Yamaizumi M, Okamura H.

Gynecol Oncol. 2001 Apr;81(1):10-7.

PMID:
11277643
18.
19.

Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen.

Theuring F, Götz W, Balling R, Korf HW, Schulze F, Herken R, Gruss P.

Oncogene. 1990 Feb;5(2):225-32.

PMID:
2157185
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk